Marion Visit 3 - Early and Aggressive LDL-C Management: Perspectives on Commonly Asked Questions
| Title: | Marion Visit 3 - Early and Aggressive LDL-C Management: Perspectives on Commonly Asked Questions |
| Topic: | Cardiology |
| Relevant Terms: | Dyslipidemia, Hyperlipidemia |
| Primary Audience: | All physicians and other healthcare professionals who treat patients with dyslipidemia. |
| Launch Date: | 13-Oct-09 |
| Credits: | 0.5 AMA PRA Category 1 Credit™ |
| Expiration Date: | 12-Oct-10 |
Learning Objectives
After completion of this activity, participants should be better able to:
- Understand the key tenets of assessing and managing dyslipidemia in clinical practice and the current evidence regarding the safety and efficacy of available LDL-C lowering therapies
- Identify at least 2 lipid lowering strategies to initiate and tailor comprehensive management treatment plans for patients with high LDL-C in order to reach and maintain targeted goals
Faculty
James Underberg, MD, MS, FACPM, FACP, FNLA
Clinical Assistant Professor of Medicine
NYU Medical School
Director, Primary Care Lipid Management Clinic
Bellevue Hospital Lipid Clinic
New York, New York
David Leaf, MD, MPH
Professor of Medicine
Director, Cardiac Rehabilitation Program
UCLA School of Medicine
Los Angeles, California
John Russell, MD
Clinical Associate Professor of Family and Community Medicine
Temple University School of Medicine
Philadelphia, Pennsylvania
Associate Director, Family Medicine Residency Program
Abington Memorial Hospital
Abington, Pennsylvania
Emily Bakerman, RN, MS, APN-C
Executive Vice President
Turnkey Solutions
River Vale, New Jersey
Clinical Assistant Professor of Medicine
NYU Medical School
Director, Primary Care Lipid Management Clinic
Bellevue Hospital Lipid Clinic
New York, New York
David Leaf, MD, MPHProfessor of Medicine
Director, Cardiac Rehabilitation Program
UCLA School of Medicine
Los Angeles, California
John Russell, MDClinical Associate Professor of Family and Community Medicine
Temple University School of Medicine
Philadelphia, Pennsylvania
Associate Director, Family Medicine Residency Program
Abington Memorial Hospital
Abington, Pennsylvania
Emily Bakerman, RN, MS, APN-CExecutive Vice President
Turnkey Solutions
River Vale, New Jersey
To Obtain CME Credits
• Read the learning objectives and faculty disclosures.
• Participate in the activity.
• Complete the post-test and activity evaluation.
• Physicians who successfully complete the post-test and evaluation will receive CME credit.
• You must score with a 70% or higher on the post-test to receive credit for this activity. You are provided with a second opportunity to retake the post-test if you do not achieve a passing score the initial time.
• All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.
Program Overview
Achieving LDL goals in patients with coronary heart disease (CHD) has resulted in a significant challenge for primary care clinicians. Despite continued efforts of treating dyslipidemia to the current NCEP-ATP lll (National Cholesterol Education Panel Adult Treatment Panel III) goals, achievement of LDL goals in patients continues to be variable. This educational session will review the current practice recommendations, clinical trials that discuss the LDL-C targets and their implication on treatment strategies and based on current data will reinforce the need for aggressive approaches for patients who are at increased risk and require significant lipid reduction.
Statement of Disclosure and Independence
• Read the learning objectives and faculty disclosures.
• Participate in the activity.
• Complete the post-test and activity evaluation.
• Physicians who successfully complete the post-test and evaluation will receive CME credit.
• You must score with a 70% or higher on the post-test to receive credit for this activity. You are provided with a second opportunity to retake the post-test if you do not achieve a passing score the initial time.
• All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.
Program Overview
Achieving LDL goals in patients with coronary heart disease (CHD) has resulted in a significant challenge for primary care clinicians. Despite continued efforts of treating dyslipidemia to the current NCEP-ATP lll (National Cholesterol Education Panel Adult Treatment Panel III) goals, achievement of LDL goals in patients continues to be variable. This educational session will review the current practice recommendations, clinical trials that discuss the LDL-C targets and their implication on treatment strategies and based on current data will reinforce the need for aggressive approaches for patients who are at increased risk and require significant lipid reduction.
Statement of Disclosure and Independence
It is the policy of Primary Care Network, Inc. to ensure all its sponsored educational activities are planned, developed, and conducted in accordance with the ACCME's Essential Areas and Policies. In accordance with ACCME requirements, Primary Care Network has Conflict of Interest and Disclosure Policies that are designed to ensure that Primary Care Network sponsored educational activities are fair balanced, independent, evidence‐based and based on scientific rigor.
Primary Care Network's Resolution of Personal Conflicts of Interest (COI) Policy aims to ensure that all conflicts are resolved prior to the activity, content is developed and presented free of commercial bias, and is in the interest of promoting improvements or quality in healthcare. All individuals who are in a position to influence and/or control content of a Primary Care Network sponsored activity are required to disclose to the participants any real or apparent conflict of interest related to the activity. The educational content is also reviewed for independence and content validation by an independent external clinical reviewer and internal clinical reviewer. Independence is also monitored through the activity and overall program evaluation process.
The opinions, ideas, recommendations, and perspectives expressed in this activity are those of the program authors and presenting faculty only and do not necessarily reflect the opinions, ideas, recommendations or perspectives of their affiliated institutions, Primary Care Network, Primary Care Education, Advisory Boards and Consultants, or the activity's commercial supporters.
Dr. Underberg is on speaker's bureaus for Abbott Labs, AstraZeneca, Forest Labs, GlaxoSmithKline, Merck, Novartis, Pfizer, Schering-Plough, and Liposcience. He is also on advisory boards for Abbott Labs and Liposcience. He is a consultant for Liposcience and has received research grants from Merck, Novartis, and Liposcience.
Primary Care Network's Resolution of Personal Conflicts of Interest (COI) Policy aims to ensure that all conflicts are resolved prior to the activity, content is developed and presented free of commercial bias, and is in the interest of promoting improvements or quality in healthcare. All individuals who are in a position to influence and/or control content of a Primary Care Network sponsored activity are required to disclose to the participants any real or apparent conflict of interest related to the activity. The educational content is also reviewed for independence and content validation by an independent external clinical reviewer and internal clinical reviewer. Independence is also monitored through the activity and overall program evaluation process.
The opinions, ideas, recommendations, and perspectives expressed in this activity are those of the program authors and presenting faculty only and do not necessarily reflect the opinions, ideas, recommendations or perspectives of their affiliated institutions, Primary Care Network, Primary Care Education, Advisory Boards and Consultants, or the activity's commercial supporters.
Dr. Underberg is on speaker's bureaus for Abbott Labs, AstraZeneca, Forest Labs, GlaxoSmithKline, Merck, Novartis, Pfizer, Schering-Plough, and Liposcience. He is also on advisory boards for Abbott Labs and Liposcience. He is a consultant for Liposcience and has received research grants from Merck, Novartis, and Liposcience.
Dr. Leaf has declared that he has no relevant financial relationships to disclose.
Dr. Russell is on the speaker's bureau for sanofi pasteur.
Ms. Bakerman declares that she has no relevant financial relationships to disclose.
Unlabeled Use Declaration
Unlabeled Use Declaration
During their presentation(s), faculty may discuss an unlabeled use or an investigational use not approved for a commercial product. Each faculty member is required to disclose this information to the audience when referring to an unlabeled or investigational use.
Review Committee Disclosure
Review Committee Disclosure
In accordance with PCN policy, all content is reviewed by external independent peer reviewers for balance, objectivity, and commercial bias. The peer reviewers, staff, and other individuals who control content have no relevant financial relationships to disclose.
Curtis P. Schreiber, MD, has received research grant support from Allergan, AmeriLabs, ANS, BioAlliance, Boston Scientific, Capnia, Endo Pharmaceuticals, GlaxoSmithKline, Hoffman La Roche, Map Pharmaceuticals, Merck & Company, Minster Pharmaceuticals, NeurAxon, Novartis, NuPath, Pfizer, Takeda, and Wyeth.
Accreditation/Designation Statement
Curtis P. Schreiber, MD, has received research grant support from Allergan, AmeriLabs, ANS, BioAlliance, Boston Scientific, Capnia, Endo Pharmaceuticals, GlaxoSmithKline, Hoffman La Roche, Map Pharmaceuticals, Merck & Company, Minster Pharmaceuticals, NeurAxon, Novartis, NuPath, Pfizer, Takeda, and Wyeth.
Accreditation/Designation Statement
Primary Care Network, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Primary Care Network designates this educational activity for a maximum of .5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Course Viewing Requirements
Acknowledgements
This activity is sponsored by Primary Care Education.
Acknowledgment of Commercial Support
If you have any questions regarding this activity, send an email to education@primarycarenet.org or call (800)769-7565.
Copyright © 2009 by Primary Care Education. All rights reserved.
Primary Care Network designates this educational activity for a maximum of .5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Course Viewing Requirements
|
PC
Internet Explorer (v6 or greater), or Firefox |
MAC
Safari |
Acknowledgements
This activity is sponsored by Primary Care Education.
Acknowledgment of Commercial Support
This activity was developed through an educational grant from Merck/Schering-Plough Pharmaceuticals.
If you have any questions regarding this activity, send an email to education@primarycarenet.org or call (800)769-7565.
Copyright © 2009 by Primary Care Education. All rights reserved.
